ArticleCancers2026

A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC Group.

Maha Hameed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.